Keefe K - Search Results

1

The effect of prinomastat (AG3340), a potent inhibitor of matrix metalloproteinases, on a subacute model of proliferative vitreoretinopathy.

Ozerdem U, Mach-Hofacre B, Cheng L, Chaidhawangul S, Keefe K, McDermott CD, Bergeron-Lynn G, Appelt K, Freeman WR. Ozerdem U, et al. Among authors: keefe k. Curr Eye Res. 2000 Jun;20(6):447-53. Curr Eye Res. 2000. PMID: 10980656

2

An animal model for cidofovir (HPMPC) toxicity: intraocular pressure and histopathologic effects.

Taskintuna I, Banker AS, Rao NA, Wiley CA, Flores-Aguilar M, Munguia D, Bergeron-Lynn G, De Clercq E, Keefe K, Freeman WR. Taskintuna I, et al. Among authors: keefe k. Exp Eye Res. 1997 May;64(5):795-806. doi: 10.1006/exer.1996.0273. Exp Eye Res. 1997. PMID: 9245910

3

The effect of prinomastat (AG3340), a synthetic inhibitor of matrix metalloproteinases, on posttraumatic proliferative vitreoretinopathy.

Ozerdem U, Mach-Hofacre B, Keefe K, Pham T, Soules K, Appelt K, Freeman WR. Ozerdem U, et al. Among authors: keefe k. Ophthalmic Res. 2001 Jan-Feb;33(1):20-3. doi: 10.1159/000055636. Ophthalmic Res. 2001. PMID: 11114600

4

Effects of topical and subconjunctival cidofovir (HPMPC) in an animal model.

Banker AS, Bergeron-Lynn G, Keefe KS, De Clercq E, Taskintuna I, Freeman WR. Banker AS, et al. Among authors: keefe ks. Curr Eye Res. 1998 Jun;17(6):560-6. Curr Eye Res. 1998. PMID: 9663845

5

Evaluation of intraocular pharmacokinetics and toxicity of prinomastat (AG3340) in the rabbit.

Cheng L, Rivero ME, Garcia CR, McDermott CD, Keefe KS, Wiley CA, Soules KA, Bergeron-Lynn G, Vekich S, Zhang K, Appelt K, Freeman WR. Cheng L, et al. Among authors: keefe ks. J Ocul Pharmacol Ther. 2001 Jun;17(3):295-304. doi: 10.1089/108076801750295326. J Ocul Pharmacol Ther. 2001. PMID: 11436949

6

Influence of intravitreal injections of HPMPC and related nucleoside analogues on intraocular pressure in guinea pig eyes.

Banker AS, De Clercq E, Taskintuna I, Keefe KS, Bergeron-Lynn G, Freeman WR. Banker AS, et al. Among authors: keefe ks. Invest Ophthalmol Vis Sci. 1998 Jun;39(7):1233-42. Invest Ophthalmol Vis Sci. 1998. PMID: 9620084

7

Intravitreal toxicology in rabbits of two preparations of 1-O-octadecyl-sn-glycerol-3-phosphonoformate, a sustained-delivery anti-CMV drug.

Cheng L, Hostetler KY, Gardner MF, Avila CP Jr, Bergeron-Lynn G, Keefe KS, Wiley CA, Freeman WR. Cheng L, et al. Among authors: keefe ks. Invest Ophthalmol Vis Sci. 1999 Jun;40(7):1487-95. Invest Ophthalmol Vis Sci. 1999. PMID: 10359331

8

Intravitreal toxicology and therapeutic efficacy of the carboxymethyl ester of the 1-O-octadecyl-sn-glycerol-3-phosphonoformate (ODG-PFA-O-Me), a novel lipid antiviral prodrug for intraocular drug delivery.

Cheng L, Hostetler KY, Gardner MF, Avila CP Jr, Bergeron-Lynn G, Keefe KS, Beadle JR, Wiley CA, Freeman WR. Cheng L, et al. Among authors: keefe ks. J Ocul Pharmacol Ther. 1999 Aug;15(4):363-77. doi: 10.1089/jop.1999.15.363. J Ocul Pharmacol Ther. 1999. PMID: 10463875

9

Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation.

Cheng L, Hostetler KY, Chaidhawangul S, Gardner MF, Beadle JR, Keefe KS, Bergeron-Lynn G, Severson GM, Soules KA, Mueller AJ, Freeman WR. Cheng L, et al. Among authors: keefe ks. Invest Ophthalmol Vis Sci. 2000 May;41(6):1523-32. Invest Ophthalmol Vis Sci. 2000. PMID: 10798672

10

Cytomegalovirus iritis.

Cheng L, Rao NA, Keefe KS, Avila CP Jr, Macdonald JC, Freeman WR. Cheng L, et al. Among authors: keefe ks. Ophthalmic Surg Lasers. 1998 Nov;29(11):930-2. Ophthalmic Surg Lasers. 1998. PMID: 9824866

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

185 results

Search Page

Filters